Interferons immune system plays a vital role in the immune response to viral infections, tumors, and other immune challenges. Interferons (IFNs) are a group of signaling proteins categorized into three main types: Type I (including IFN-alpha and IFN-beta), Type II (IFN-gamma), and Type III (IFN-lambda). Each type has distinct functions and mechanisms of action that are crucial for modulating the immune system.
At AnyGenes, we provide state-of-the-art tools and products designed to aid researchers in studying interferon responses and their associated signaling pathways. Our products help uncover the intricacies of how interferons interact with the immune system, supporting advancements in treatments and diagnostics.
Overview of interferon signaling pathways in vertebrate hosts. Production of interferons (IFNs) begins with the binding of viral molecules, such as genomic nucleic acids, to either cell surface or intracellular pattern recognition receptors (PRRs) [18,19]. The resulting signaling cascade activates transcription and secretion of IFNs, which then bind to their associated IFN receptor on the same and nearby cells. Binding of IFNs to their receptors activates a signal cascade by Janus tyrosine kinases (JAK) and tyrosine kinase (TYK) that leads to the phosphorylation of STAT1 and/or STAT2 [9,15]. For type I and III IFNs, STAT1 and STAT2 complex with IRF9 and bind to IFN-stimulated response elements (ISREs) to express IFN-stimulated genes (ISGs). For type II IFNs, phosphorylated STAT1 dimers bind to gamma-activated site (GAS) elements for ISG production [9,15]. In turn, ISGs mediate antiviral effects directly within infected cells, or further induce innate and adaptive immune responses [3,120].
Interferons exert their effects by binding to specific receptors on the surface of target cells, activating intracellular signaling pathways that enhance antiviral defenses and promote immune regulation. Upon binding, interferons trigger the expression of various genes involved in immune responses, including.
Interferons serve multiple functions within the immune system:
In addition to their antiviral properties, interferons are increasingly recognized for their role in cancer immunotherapy. Type I interferons, particularly IFN-alpha, have been used to treat certain cancers, such as melanoma and chronic myeloid leukemia, by enhancing the immune response against tumor cells. They help to stimulate T cell activity and promote the expression of tumor-associated antigens, making cancer cells more visible to the immune system.
Interferons are used clinically for various conditions, including:
Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file
and send it at
contact@anygenes.com
to get started on your project.